CYP26C1: A Potential Drug Target for Multiple Tissues (G340665)

Target Name: CYP26C1

NCBI ID: G340665

CYP26C1

CYP26C1: A Potential Drug Target for Multiple Tissues

CYP26C1, also known as CP26C_HUMAN, is a protein that is expressed in various tissues throughout the body, including the liver, lung, and heart. It is a key regulator of cell signaling pathways and has been identified as a potential drug target in several diseases.

The CYP26C1 protein is composed of 26 subunits that are encoded by the human chromosome 18. It is expressed in a variety of tissues and is involved in several different signaling pathways. For example, it is involved in the regulation of cell adhesion, cell growth, and cell survival. It is also involved in the regulation of angiogenesis, the formation of new blood vessels, and in the regulation of inflammation.

One of the key functions of CYP26C1 is its role in cell signaling pathways. It is a key regulator of the TGF-β pathway, a signaling pathway that is involved in cell growth, differentiation, and survival. This pathway is important for the development and maintenance of tissues and organs, and it is thought to be involved in the development of many diseases, including cancer.

In addition to its role in cell signaling pathways, CYP26C1 is also involved in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels are formed, and it is an important pathway for the development of tissues and organs. CYP26C1 is involved in the regulation of angiogenesis by controlling the production of extracellular matrix (ECM) proteins, which are important for the formation of new blood vessels.

CYP26C1 is also involved in the regulation of inflammation. It is a key regulator of the production of pro-inflammatory cytokines, which are important for the regulation of immune responses and inflammation. This protein is also involved in the regulation of the production of anti-inflammatory cytokines, which help to counteract the pro-inflammatory effects of cytokines.

Despite its involvement in several different signaling pathways, CYP26C1 is not yet a well-studied protein. There is limited research on the functions of this protein, and much of its biology is still unknown. However, its potential as a drug target is based on its involvement in several different signaling pathways.

One of the potential benefits of targeting CYP26C1 is its potential to treat diseases that are caused by the overproduction or underproduction of ECM proteins. For example, ECM proteins are often produced in response to mechanical stress, and their production is regulated by several different signaling pathways, including the TGF-β pathway. Targeting CYP26C1 could potentially lead to the development of new treatments for diseases that are caused by the overproduction or underproduction of ECM proteins.

Another potential benefit of targeting CYP26C1 is its potential to treat diseases that are caused by the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels are formed, and it is an important pathway for the development and maintenance of tissues and organs. Targeting CYP26C1 could potentially lead to the development of new treatments for diseases that are caused by the regulation of angiogenesis.

Targeting CYP26C1 could also potentially lead to the development of new treatments for other diseases. For example, CYP26C1 is involved in the regulation of cell adhesion, cell growth, and cell survival, and it is thought to be involved in the development and maintenance of tissues and organs. Targeting CYP26C1 could potentially lead to the development of new treatments for diseases that are caused by the regulation of these processes.

In conclusion, CYP26C1 is a protein that is expressed in various tissues throughout the body and is involved in several different signaling pathways. It is a potential drug target for several different diseases, including those caused by the overproduction or underproduction of ECM proteins, the regulation of angiogenesis, and the regulation of cell

Protein Name: Cytochrome P450 Family 26 Subfamily C Member 1

Functions: Plays a role in retinoic acid metabolism. Acts on retinoids, including all-trans-retinoic acid (RA) and its stereoisomer 9-cis-RA (preferred substrate)

The "CYP26C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP26C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets